DOC News

Healthpeak Properties Raises 2026 Earnings Guidance Following Completion of the Janus Living IPO, Accretive Capital Allocation, and Strong First Quarter 2026 Results

Form 8-K

Healthpeak Properties Announces Dates of First Quarter 2026 Earnings Release, Conference Call, and Webcast

Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Second Quarter of 2026

Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation

Healthpeak Properties Closes New $400 Million Delayed-Draw Term Loan Facility

Healthpeak Properties and Janus Living Announce Closing of Janus Living Initial Public Offering

Form 8-K

Healthpeak Properties and Janus Living Announce Pricing of Upsized $840 Million Janus Living Initial Public Offering

Healthpeak Properties and Janus Living Announce Launch of Janus Living Initial Public Offering